Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
Risk-directed childhood leukemia treatment takes a step forward
St. Jude findings highlight genomic analysis as a tool to extend risk-directed therapy and improve outcomes for children with the most common pediatric cancer.
-
Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma
Results from a collaborative multi-site clinical trial show the success of adding brentuximab vedotin, reducing radiation.
-
Martine Roussel, Ph.D., elected to the AACR Academy Class of 2021
Martine Roussel, Ph.D., has been elected to the 2021 Class of Fellows of the American Association for Cancer Research.
-
ATRT molecular groups: looking at the biology from the clinic
Scientists at St. Jude Children’s Research Hospital are learning more about what the molecular groups of a rare pediatric brain tumor mean for clinical care.
-
St. Jude receives $9.9 million to advance cures for hard-to-treat pediatric cancer
St. Jude scientists have been selected for an international collaborative research effort to advance treatment for some leading causes of childhood cancer death.
-
Delaying the first spinal tap may lower risk of pediatric leukemia relapse
An international research team has identified clinical factors associated with the risk of central nervous system relapse in patients with the most common childhood cancer.